Cargando…

Ketamine and the coagulation response during and after cardiopulmonary bypass

Detalles Bibliográficos
Autores principales:	Husedzinovic, I, Barisin, S, Bradic, N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098295/ http://dx.doi.org/10.1186/cc3208

Ejemplares similares

Pretreatment with levosimendan improves outcome in off-pump coronary artery bypass grafting
por: Husedzinovic, I, et al.
Publicado: (2013)

Cardioprotection with sevoflurane during off-pump coronary artery surgery
por: Husedzinovic, I, et al.
Publicado: (2013)

Fibrinolysis during cardiopulmonary bypass detected with thromboelastography
por: Hájek, R, et al.
Publicado: (2007)

Influence of amiodarone treatment on inflammation during cardiopulmonary bypass
por: Delle Karth, G, et al.
Publicado: (2005)

Anesthesiology management for the transcatheter aortic valve implantation
por: Bradic, N, et al.
Publicado: (2013)

Sublingual microcirculation is impaired during cardiopulmonary bypass in cardiac surgery
por: den Uil, C, et al.
Publicado: (2007)

Use of procalcitonin for identification of postoperative complications after coronary artery bypass surgery with cardiopulmonary bypass
por: Baysal, A, et al.
Publicado: (2014)

Does cardiopulmonary bypass affect the procalcitonin level?
por: Kalay, F, et al.
Publicado: (2005)

Factors associated with excessive bleeding in cardiopulmonary bypass patients
por: Jimenez Rivera, J, et al.
Publicado: (2006)

Continuous pulse contour analysis after cardiopulmonary bypass in cardiac surgery
por: Sander, M, et al.
Publicado: (2005)

Microvascular effects of pulsatile versus nonpulsatile perfusion during cardiopulmonary bypass
por: Elbers, PW, et al.
Publicado: (2010)

Does cardiopulmonary bypass increase the risk of postoperative acute kidney injury after coronary artery bypass grafting?
por: Karmali, A, et al.
Publicado: (2015)

Hematocrit of 20% versus 25% during normothermic cardiopulmonary bypass for elective coronary artery bypass graft surgery
por: von Heymann, C, et al.
Publicado: (2005)

Endothelial protein C receptor expression after cardiopulmonary bypass in adult cardiac surgical patients
por: Hajek, R, et al.
Publicado: (2010)

Does the use of a cytokine 'filter' during cardiopulmonary bypass make sense?
por: Clermont, G, et al.
Publicado: (2004)

Is procalcitonin a valuable marker for identification of postoperative complications after coronary artery bypass graft surgery with cardiopulmonary bypass?
por: Baysal, A, et al.
Publicado: (2015)

Macrophage chemoattractant protein 1 and outcome in cardiopulmonary bypass
por: Pereira, KC, et al.
Publicado: (2005)

Complement activation and excessive bleeding in cardiopulmonary bypass surgery
por: Iribarren, J, et al.
Publicado: (2007)

Endotoxemia related to cardiopulmonary bypass is associated with increased risk of infection after cardiac surgery
por: Klein, DJ, et al.
Publicado: (2011)

Predictive genetic factors for bleeding in cardiac surgery patients with cardiopulmonary bypass
por: Iribarren Sarrias, J, et al.
Publicado: (2006)

Oral neutrophil quantitation in patients undergoing elective cardiopulmonary bypass
por: Wilcox, ME, et al.
Publicado: (2012)

Impact of body mass index on postoperative bleeding in cardiopulmonary bypass
por: Brouard, M, et al.
Publicado: (2007)

Tissue oxygen saturation during anaesthesia, cardiopulmonary bypass and intensive care stay for cardiac surgery
por: Sanders, J, et al.
Publicado: (2008)

Effectiveness of an underbody forced warm-air blanket in preventing postoperative hypothermia after coronary artery bypass graft surgery with normothermic cardiopulmonary bypass
por: Teodorczyk, JE, et al.
Publicado: (2009)

Clinical outcome and mortality associated with postoperative low cardiac output after cardiopulmonary bypass: a cohort study
por: Jimenez, J, et al.
Publicado: (2008)

Intravenous anesthesia with S-(+)-ketamine for 'on-pump' coronary artery bypass surgery: hemodynamic profile and effect on troponin T levels
por: Neuhaeuser, C, et al.
Publicado: (2007)

Relative adrenal insufficiency in cardiopulmonary bypass surgery patients: impact on the postoperative hemodynamic status
por: Jimenez, J, et al.
Publicado: (2009)

Coagulation and neonatal bypass: an assessment of changes in coagulation factor concentration during cardiopulmonary bypass in neonates, with modified ultrafiltration
por: Arnold, P, et al.
Publicado: (1999)

Safety and effectiveness of different treatment regimes with tranexamic acid in elective cardiopulmonary bypass patients
por: Iribarren, JL, et al.
Publicado: (2011)

Perioperative risk factors for serious gastrointestinal complications treated by laparotomy after cardiac surgery using cardiopulmonary bypass
por: Soos, P, et al.
Publicado: (2011)

Effects of perfusion pressure on the splanchnic circulation after cardiopulmonary bypass: a randomized double cross-over study
por: McNicol, L, et al.
Publicado: (2014)

Cardiopulmonary bypass and recombinant plasminogen activator for treatment of experimental fatal pulmonary embolism
por: Kjærgaard, B, et al.
Publicado: (2007)

Do erythrocytes subjected to cardiopulmonary bypass exhibit changes in their membrane mechanical properties?
por: Clark, T, et al.
Publicado: (2013)

Postoperative dose of tranexamic acid decreases postoperative bleeding and inflammatory response associated with cardiopulmonary bypass: a randomized, double-blind study
por: Brouard, M, et al.
Publicado: (2008)

Vasoplegic syndrome after cardiopulmonary bypass surgery – associated factors and clinical outcomes: a nested case-control study
por: Iribarren, J, et al.
Publicado: (2007)

Etomidate and relative adrenal insufficiency in cardiopulmonary bypass surgery: impact on the postoperative hemodynamic status
por: Lorenzo, L, et al.
Publicado: (2008)

Effects of cardiopulmonary bypass on the accuracy of non-invasive hemoglobin measurement by pulse co-oximetry
por: Tokuda, K, et al.
Publicado: (2015)

Impact of antiplatelet therapy and cardiopulmonary bypass on platelet function in patients undergoing coronary artery bypass grafting using multiple electrode aggregometry
por: Gersak, B, et al.
Publicado: (2013)

Pharmacological preconditioning with the guanylate cyclase activator cinaciguat (BAY 58-2667) protects against reperfusion injury after cardiopulmonary bypass
por: Radovits, Tamás, et al.
Publicado: (2009)

Neurological damage due to coagulation and fat release during cardiopulmonary bypass
por: van Oeveren, Willem
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_gh1hodh0l32l4kijgsj3cqbont